<DOC>
	<DOCNO>NCT03091010</DOCNO>
	<brief_summary>Study population : Patients attend Out Patient Department admit Institute Liver Biliary Sciences . Study design : Prospective randomized control trial Study period : One year- January 2017- December 2018 Sample size : 130 ( 65 case group ) Intervention : The subject give Fecal Microbiota Transplantation NJ tube place admission hospital . Participants administer processed fecal microbiota sample collect related unrelated healthy donor period 7 day . Monitoring assessment : The recipient monitor every day Fecal Microbiota Transplantation therapy . The recipient undergo physical examination , complete blood count , baseline chest X ray , serum procalcitonin , CRP Tumor Necrosis Factor alpha level , Liver Function Tests , Kidney Function Tests , International Normalized Ratio arterial ammonia , day 0,4,7,14,28,90,180,270 365 start therapy . Microbiota analysis donor do baseline recipient do day 0,7,28,90 &amp; 180 .</brief_summary>
	<brief_title>A Comparison Fecal Microbiota Transplantation Steroid Therapy Patients With Severe Alcoholic Hepatitis .</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Alcoholic</mesh_term>
	<criteria>Patients severe alcoholic hepatitis . Eligible steroid therapy . Upper gastrointestinal bleed within past one month . Active sepsis Serum creatinine &gt; 1.5 mg/dl ( Hepato renal syndrome ) Intestinal paralysis Hepatic extrahepatic malignancy Disseminated intravascular coagulation Discriminant Function ( DF ) &gt; 90</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>